Key result
Higher admission neutrophil counts linked to ~20% greater risk of angiographic no-reflow after STEMI PCI.
Why the study?
The no-reflow phenomenon during primary PCI in STEMI patients leads to poor outcomes, and the relationship between admission neutrophil counts and angiographic no-reflow was unclear.
Do admission neutrophil counts predict angiographic no-reflow in patients with STEMI undergoing primary PCI?
Observational (n=217)
Do admission neutrophil counts predict angiographic no-reflow in patients with STEMI undergoing primary PCI?
Higher admission neutrophil counts independently predict angiographic no-reflow after primary PCI in STEMI patients, suggesting its utility for early risk stratification.
Answers are grounded in this paper and cite their sources.
May aid risk stratification for no-reflow in STEMI; hypothesis-generating and requires prospective validation.
BACKGROUND: The no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction (STEMI) can lead to poor outcomes. Increased neutrophil counts have been associated with an increased risk of adverse clinical events after acute myocardial infarction (AMI). The aim of this study was to assess the relation between admission neutrophil counts and angiographic no-reflow after PPCI. METHODS: A total of 217 patients with acute STEMI who underwent PPCI, were enrolled. The patients were divided into two groups: no-reflow and normal-reflow. The neutrophil counts and other laboratory parameters were measured on admission before PPCI. RESULTS: There were 41 patients (18.9%) in the no-reflow group and 176 patients in the normal-reflow group. Patients with no-reflow were older (68.0 ± 11.7 years vs 60.7 ± 13.2 years, P = 0.019) and had significantly higher admission neutrophil counts (9.02 ± 3.97 × 109/L vs 7.57 ± 2.82 × 109/L, P = 0.007). Also, high-sensitivity C-reactive protein (hsCRP), white blood counts, monocyte counts were significantly higher while haemoglobin values were significantly lower in the no-reflow group. In multivariate analysis, neutrophil counts remained a strong independent predictor of angiographic no-reflow (odds ratio 1,200, 95% confidence interval 1.073-1.342, P = 0.001) together with age (odds ratio 1.041, 95% confidence interval 1.012-1.071, P = 0.005). CONCLUSIONS: Neutrophil counts on admission and age were independent clinical predictors of no-reflow following primary PCI in patients with STEMI. Our findings suggest that admission neutrophil counts may be available for early risk stratification of no-reflow after primary PCI and might allow the improvement of strategies to prevent this phenomenon.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2016) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=217). Admission neutrophil counts was evaluated on Angiographic no-reflow (OR 1.200, 95% CI 1.073-1.342, p=0.001). Higher admission neutrophil counts independently predicted angiographic no-reflow following primary percutaneous coronary intervention in patients with STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: